Literature DB >> 11799909

A serological survey of minute virus of canines (MVC; canine parvovirus type-1) in dogs in the Tokai area of Japan.

A Hashimoto1, M Takiguchi, K Hirai, H Kida, L E Carmichael.   

Abstract

A serological survey for antibodies to minute virus of canines (MVC) by use of a hemagglutination-inhibition (HI) test was performed on sera collected from dogs in the Tokai area of Japan. Forty-one of 266 (15.4%) sera had positive titers of 1:40 or higher against the MVC. Results suggest that MVC may have been present in dogs in Japan since, at least, 1990. From this serosurvey, MVC appears to be established in the dog population in Japan. MVC may have a role as a newly recognized viral pathogen of dogs in Japan.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11799909

Source DB:  PubMed          Journal:  Jpn J Vet Res        ISSN: 0047-1917            Impact factor:   0.649


  4 in total

1.  Virologic and serologic identification of minute virus of canines (canine parvovirus type 1) from dogs in Japan.

Authors:  Masami Mochizuki; Michiru Hashimoto; Takayuki Hajima; Mitsuyoshi Takiguchi; Akira Hashimoto; Yumi Une; Frank Roerink; Takahisa Ohshima; Colin R Parrish; Leland E Carmichael
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Sequence analysis of an Asian isolate of minute virus of canines (canine parvovirus type 1).

Authors:  Takahisa Ohshima; Masahiko Kishi; Masami Mochizuki
Journal:  Virus Genes       Date:  2004-12       Impact factor: 2.332

3.  A minute virus of canines (MVC: canine bocavirus) isolated from an elderly dog with severe gastroenteritis, and phylogenetic analysis of MVC strains.

Authors:  T Ohshima; K Kawakami; T Abe; M Mochizuki
Journal:  Vet Microbiol       Date:  2010-04-09       Impact factor: 3.293

4.  Divergent minute virus of canines strains identified in illegally imported puppies in Italy.

Authors:  M Campalto; M Carrino; L Tassoni; G Rizzo; M C Rossmann; M Cocchi; P De Benedictis; Maria Serena Beato
Journal:  Arch Virol       Date:  2020-10-08       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.